478 related articles for article (PubMed ID: 24040204)
1. TRAIL-deficiency accelerates vascular calcification in atherosclerosis via modulation of RANKL.
Di Bartolo BA; Cartland SP; Harith HH; Bobryshev YV; Schoppet M; Kavurma MM
PLoS One; 2013; 8(9):e74211. PubMed ID: 24040204
[TBL] [Abstract][Full Text] [Related]
2. Increased calcification in osteoprotegerin-deficient smooth muscle cells: Dependence on receptor activator of NF-κB ligand and interleukin 6.
Callegari A; Coons ML; Ricks JL; Rosenfeld ME; Scatena M
J Vasc Res; 2014; 51(2):118-31. PubMed ID: 24642764
[TBL] [Abstract][Full Text] [Related]
3. Bone marrow- or vessel wall-derived osteoprotegerin is sufficient to reduce atherosclerotic lesion size and vascular calcification.
Callegari A; Coons ML; Ricks JL; Yang HL; Gross TS; Huber P; Rosenfeld ME; Scatena M
Arterioscler Thromb Vasc Biol; 2013 Nov; 33(11):2491-500. PubMed ID: 23990207
[TBL] [Abstract][Full Text] [Related]
4. TLR2 Promotes Vascular Smooth Muscle Cell Chondrogenic Differentiation and Consequent Calcification via the Concerted Actions of Osteoprotegerin Suppression and IL-6-Mediated RANKL Induction.
Lee GL; Yeh CC; Wu JY; Lin HC; Wang YF; Kuo YY; Hsieh YT; Hsu YJ; Kuo CC
Arterioscler Thromb Vasc Biol; 2019 Mar; 39(3):432-445. PubMed ID: 30626205
[TBL] [Abstract][Full Text] [Related]
5. Osteoprotegerin inactivation accelerates advanced atherosclerotic lesion progression and calcification in older ApoE-/- mice.
Bennett BJ; Scatena M; Kirk EA; Rattazzi M; Varon RM; Averill M; Schwartz SM; Giachelli CM; Rosenfeld ME
Arterioscler Thromb Vasc Biol; 2006 Sep; 26(9):2117-24. PubMed ID: 16840715
[TBL] [Abstract][Full Text] [Related]
6. RANKL, but Not R-Spondins, Is Involved in Vascular Smooth Muscle Cell Calcification through LGR4 Interaction.
Fernández-Villabrille S; Martín-Vírgala J; Martín-Carro B; Baena-Huerta F; González-García N; Gil-Peña H; Rodríguez-García M; Fernández-Gómez JM; Fernández-Martín JL; Alonso-Montes C; Naves-Díaz M; Carrillo-López N; Panizo S
Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38891922
[TBL] [Abstract][Full Text] [Related]
7. Vascular calcification in type-2 diabetes and cardiovascular disease: Integrative roles for OPG, RANKL and TRAIL.
Harper E; Forde H; Davenport C; Rochfort KD; Smith D; Cummins PM
Vascul Pharmacol; 2016 Jul; 82():30-40. PubMed ID: 26924459
[TBL] [Abstract][Full Text] [Related]
8. The function and meaning of receptor activator of NF-κB ligand in arterial calcification.
Nie B; Zhou SQ; Fang X; Zhang SY; Guan SM
J Huazhong Univ Sci Technolog Med Sci; 2015 Oct; 35(5):666-671. PubMed ID: 26489619
[TBL] [Abstract][Full Text] [Related]
9. No influence of OPG and its ligands, RANKL and TRAIL, on proliferation and regulation of the calcification process in primary human vascular smooth muscle cells.
Olesen M; Skov V; Mechta M; Mumm BH; Rasmussen LM
Mol Cell Endocrinol; 2012 Oct; 362(1-2):149-56. PubMed ID: 22698523
[TBL] [Abstract][Full Text] [Related]
10. Advanced glycation end-product Nε-carboxymethyl-Lysine accelerates progression of atherosclerotic calcification in diabetes.
Wang Z; Jiang Y; Liu N; Ren L; Zhu Y; An Y; Chen D
Atherosclerosis; 2012 Apr; 221(2):387-96. PubMed ID: 22305260
[TBL] [Abstract][Full Text] [Related]
11. Vitamin K2 can suppress the expression of Toll-like receptor 2 (TLR2) and TLR4, and inhibit calcification of aortic intima in ApoE
Wang Z; Wang Z; Zhu J; Long X; Yan J
Vascular; 2018 Feb; 26(1):18-26. PubMed ID: 28587577
[TBL] [Abstract][Full Text] [Related]
12. Smooth Muscle Cell-Derived Interleukin-17C Plays an Atherogenic Role via the Recruitment of Proinflammatory Interleukin-17A+ T Cells to the Aorta.
Butcher MJ; Waseem TC; Galkina EV
Arterioscler Thromb Vasc Biol; 2016 Aug; 36(8):1496-506. PubMed ID: 27365405
[TBL] [Abstract][Full Text] [Related]
13. A novel role of FKN/CX3CR1 in promoting osteogenic transformation of VSMCs and atherosclerotic calcification.
Yang T; Guo L; Chen L; Li J; Li Q; Pi Y; Zhu J; Zhang L
Cell Calcium; 2020 Nov; 91():102265. PubMed ID: 32814243
[TBL] [Abstract][Full Text] [Related]
14. Tumor necrosis factor-related apoptosis-inducing ligand and vascular calcification.
Chasseraud M; Liabeuf S; Mozar A; Mentaverri R; Brazier M; Massy ZA; Kamel S
Ther Apher Dial; 2011 Apr; 15(2):140-6. PubMed ID: 21426505
[TBL] [Abstract][Full Text] [Related]
15. The receptor activator of nuclear factor κΒ ligand receptor leucine-rich repeat-containing G-protein-coupled receptor 4 contributes to parathyroid hormone-induced vascular calcification.
Carrillo-López N; Martínez-Arias L; Alonso-Montes C; Martín-Carro B; Martín-Vírgala J; Ruiz-Ortega M; Fernández-Martín JL; Dusso AS; Rodriguez-García M; Naves-Díaz M; Cannata-Andía JB; Panizo S
Nephrol Dial Transplant; 2021 Mar; 36(4):618-631. PubMed ID: 33367746
[TBL] [Abstract][Full Text] [Related]
16. RANKL increases vascular smooth muscle cell calcification through a RANK-BMP4-dependent pathway.
Panizo S; Cardus A; Encinas M; Parisi E; Valcheva P; López-Ongil S; Coll B; Fernandez E; Valdivielso JM
Circ Res; 2009 May; 104(9):1041-8. PubMed ID: 19325147
[TBL] [Abstract][Full Text] [Related]
17. Cross-talk of receptor activator of nuclear factor-κB ligand signaling with renin-angiotensin system in vascular calcification.
Osako MK; Nakagami H; Shimamura M; Koriyama H; Nakagami F; Shimizu H; Miyake T; Yoshizumi M; Rakugi H; Morishita R
Arterioscler Thromb Vasc Biol; 2013 Jun; 33(6):1287-96. PubMed ID: 23580147
[TBL] [Abstract][Full Text] [Related]
18. Estrogen Receptor Control of Atherosclerotic Calcification and Smooth Muscle Cell Osteogenic Differentiation.
McRobb LS; McGrath KCY; Tsatralis T; Liong EC; Tan JTM; Hughes G; Handelsman DJ; Heather AK
Arterioscler Thromb Vasc Biol; 2017 Jun; 37(6):1127-1137. PubMed ID: 28473445
[TBL] [Abstract][Full Text] [Related]
19. The P2Y
Qian S; Regan JN; Shelton MT; Hoggatt A; Mohammad KS; Herring PB; Seye CI
Atherosclerosis; 2017 Feb; 257():38-46. PubMed ID: 28038380
[TBL] [Abstract][Full Text] [Related]
20. Role of Wnt/β-Catenin Pathway in the Arterial Medial Calcification and Its Effect on the OPG/RANKL System.
Nie B; Zhang SY; Guan SM; Zhou SQ; Fang X
Curr Med Sci; 2019 Feb; 39(1):28-36. PubMed ID: 30868488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
